Viridian Therapeutics, Inc.
elegrobart
thyroid eye disease (TED)
Countdown
267days
Catalyst readout · ~ Mar 31, 2027 estimated
What's at stake
A key catalyst for elegrobart (thyroid eye disease (TED)) is expected ~ Mar 31, 2027.
Primary source
· SEC 8-K
verified 15h ago
“BLA submission anticipated in Q1 2027”